Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-13-013886
Filing Date
2013-06-04
Accepted
2013-06-04 17:30:59
Documents
1
Period of Report
2013-05-31

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 20950
  Complete submission text file 0001225208-13-013886.txt   22301
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Issuer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 755 PAGE MILL ROAD, SUITE A-200 PALO ALTO CA 94304-1005
Business Address
GAITHER JAMES C (Reporting) CIK: 0001199037 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 13892405